H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10556-10568

  Morrison, Juliet ^a   Josset, Laurence ^a   Tchitchek, Nicolas ^a   Chang, Jean ^a   Belser, Jessica A ^b   Swayne, David E ^c   Pantin Jackwood, Mary J ^c   Tumpey, Terrence M ^b   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; IMMUNE RESPONSE; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H7N9; LIPID METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPANISH INFLUENZA; STRAIN DIFFERENCE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENETICS; HUMAN; INFLUENZA; MALE; METABOLISM; MORTALITY; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

CYTOKINE; TRANSCRIPTOME;

ANIMALS; CYTOKINES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MICE; MICE, INBRED BALB C; TRANSCRIPTOME; VIRULENCE;

EID: 84906346490     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00570-14     Document Type: Article

References (72)

1. WHO. 2014. WHO risk assessment: human infections with avian influenza A(H7N9) virus-21January 2014. WHO, Geneva, Switzerland. http://www.who.int/influenza/human_animal_interface/RiskAssessment _H7N9_21Jan14.pdf?ua=1.
2. Claas EC, de Jong JC, van Beek R, Rimmelzwaan GF, Osterhaus AD. 1998. Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 16:977-978. http://dx.doi.org/10.1016/S0264-410X(98)00005-X.
3. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477. http://dx.doi.org/10.1016/S0140-6736(97)11212-0.
4. CDC. 2012. Notes from the field: highly pathogenic avian influenza A (H7N3) virus infection in poultry workers-Jalisco, Mexico, July 2012. MMWR Morb. Mortal. Wkly. Rep. 61:726-727.
5. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat Vennema HH, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bosman A. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587-593. http://dx.doi.org/10.1016/S0140-6736(04)15589-X.
6. Puzelli S, Di Trani L, Fabiani C, Campitelli L, De Marco MA, Capua I, Aguilera JF, Zambon M, Donatelli I. 2005. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J. Infect. Dis. 192:1318-1322. http://dx.doi.org/10 .1086/444390.
7. ECDC. 2014. Updated rapid risk assessment: human infection with a novel avian influenza A(H7N9) virus, China (third update)-27 January 2014. ECDC, Stockholm, Sweden. http://www.ecdc.europa.eu/en/publications /Publications/influenza-AH7N9-China-rapid-risk-assessment-27-January-2 014.pdf.
8. CDC. 17 January 2014. Avian influenza A (H7N9) virus. CDC, Atlanta, GA. http://www.cdc.gov/flu/avianflu/h7n9-virus.htm.
9. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925. http://dx.doi.org/10.1016/S0140-6736(13)60903-4.
10. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368:1888 -1897. http://dx.doi.org/10 .1056/NEJMoa1304459.
11. Morens DM, Taubenberger JK, Fauci AS. 2013. H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity. mBio 4:e00445-13. http://dx.doi.org/10.1128/mBio.00445-13.
12. Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, van Boheemen S, de Meulder D, Lexmond P, Linster M, Herfst S, Smith DJ, van den Brand JM, Burke DF, Kuiken T, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2013. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501:560-563. http://dx.doi.org /10.1038/nature12476.
13. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J, Katz JM, Tumpey TM. 2013. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556-559. http://dx.doi.org/10.1038/nature12391.
14. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, Zhao D, Kishida N, Shirakura M, de Vries RP, Shichinohe S, Okamatsu M, Tamura T, Tomita Y, Fujimoto N, Goto K, Katsura H, Kawakami E, Ishikawa I, Watanabe S, Ito M, Sakai-Tagawa Y, Sugita Y, Uraki R, Yamaji R, Eisfeld AJ, Zhong G, Fan S, Ping J, Maher EA, Hanson A, Uchida Y, Saito T, Ozawa M, Neumann G, Kida H, Odagiri T, Paulson JC, Hasegawa H, Tashiro M, Kawaoka Y. 2013. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551-555. http: //dx.doi.org/10.1038/nature12392.
15. Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, Zhang Y, Shi Y, Yang L, Zhu W, Bai T, Qin K, Lan Y, Zou S, Guo J, Dong J, Dong L, Zhang Y, Wei H, Li X, Lu J, Liu L, Zhao X, Li X, Huang W, Wen L, Bo H, Xin L, Chen Y, Xu C, Pei Y, Yang Y, Zhang X, Wang S, Feng Z, Han J, Yang W, Gao GF, Wu G, Li D, Wang Y, Shu Y. 2013. Biological features of novel avian influenza A (H7N9) virus. Nature 499:500-503. http://dx.doi .org/10.1038/nature12379.
16. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MH, Huang SS, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LL, Webster RG, Webby RJ, Peiris JS, Guan Y, Shu Y. 2013. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186. http://dx.doi.org/10.1126/science.1239844.
17. Tharakaraman K, Jayaraman A, Raman R, Viswanathan K, Stebbins NW, Johnson D, Shriver Z, Sasisekharan V, Sasisekharan R. 2013. Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell 153:1486-1493. http://dx.doi.org/10.1016/j.cell.2013.05.034.
18. Shi Y, Zhang W, Wang F, Qi J, Wu Y, Song H, Gao F, Bi Y, Zhang Y, Fan Z, Qin C, Sun H, Liu J, Haywood J, Liu W, Gong W, Wang D, Shu Y, Wang Y, Yan J, Gao GF. 2013. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 11:243-247. http://dx.doi.org/10.1126/science.1242917.
19. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J, Wang G, Chen Y, Liu L, Liang L, Li Y, Fan J, Wang J, Li W, Guan L, Li Q, Yang H, Chen P, Jiang L, Guan Y, Xin X, Jiang Y, Tian G, Wang X, Qiao C, Li C, Bu Z, Chen H. 2013. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341:410-414. http: //dx.doi.org/10.1126/science.1240532.
20. Josset L, Zeng H, Kelly SM, Tumpey TM, Katze MG. 2014. Transcriptomic characterization of the novel avian origin influenza A (H7N9) virus: specific and intermediate host-response between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. mBio 5:e01102-13. http://dx.doi.org/10.1128/mBio.01102-13.
21. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, Garcia-Sastre A, Swayne DE, Katze MG. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443:578-581. http://dx.doi.org/10.1038/nature05181.
22. Cilloniz C, Pantin-Jackwood MJ, Ni C, Goodman AG, Peng X, Proll SC, Carter VS, Rosenzweig ER, Szretter KJ, Katz JM, Korth MJ, Swayne DE, Tumpey TM, Katze MG. 2010. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J. Virol. 84:7613-7624. http://dx.doi .org/10.1128/JVI.00553-10.
23. Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Katz JM, Tumpey TM. 2007. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J. Virol. 81:11139-11147. http://dx.doi.org/10.1128/JVI .01235-07.
24. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:1356-1361. http://dx.doi.org/10.1073/pnas.0308352100.
25. de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2005. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J. Virol. 79:12401-12407. http://dx.doi.org/10.1128/JVI.79.19.12401-12407.2005.
26. Joseph T, McAuliffe J, Lu B, Jin H, Kemble G, Subbarao K. 2007. Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model. J. Virol. 81:10558-10566. http://dx.doi.org /10.1128/JVI.00970-07.
27. Josset L, Belser JA, Pantin-Jackwood MJ, Chang JH, Chang ST, Belisle SE, Tumpey TM, Katze MG. 2012. Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation. J. Virol. 86:7192-7206. http://dx.doi.org/10.1128/JVI.00563-12.
28. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S, Tumpey TM, Katz JM. 2007. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J. Virol. 81:12439-12449. http://dx .doi.org/10.1128/JVI.01134-07.
29. Smyth GK. 2005. Limma: linear models for microarray data, p 397-420. In Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S (ed), Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
30. Kruskal JB, Wish M. 1978. Multidimensional scaling. Methods 116:463- 504.
31. Venables WN, Ripley BD. 2002. Modern applied statistics with S (statistics and computing). Springer, New York, NY.
32. Baranovich T, Burnham AJ, Marathe BM, Armstrong J, Guan Y, Shu Y, Peiris JM, Webby RJ, Webster RG, Govorkova EA. 2013. The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jit554.
33. Mok CK, Lee HH, Chan MC, Sia SF, Lestra M, Nicholls JM, Zhu H, Guan Y, Peiris JM. 2013. Pathogenicity of the novel A/H7N9 influenza virus in mice. mBio 4:e00362-13. http://dx.doi.org/10.1128/mBio.00362-13.
34. Gao P, Watanabe S, Ito T, Goto H, Wells K, McGregor M, Cooley AJ, Kawaoka Y. 1999. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol. 73:3184-3189.
35. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:5903-5911.
36. Maines TR, Lu XH, Erb SM, Edwards L, Guarner J, Greer PW, Nguyen DC, Szretter KJ, Chen LM, Thawatsupha P, Chittaganpitch M, Waicharoen S, Nguyen DT, Nguyen T, Nguyen HH, Kim JH, Hoang LT, Kang C, Phuong LS, Lim W, Zaki S, Donis RO, Cox NJ, Katz JM, Tumpey TM. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79:11788-11800. http://dx.doi.org/10.1128/JVI.79.18.11788-11800.2005.
37. Brandes M, Klauschen F, Kuchen S, Germain RN. 2013. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197-212. http://dx.doi.org/10.1016/j.cell.2013.06.013.
38. Chang ST, Tchitchek N, Ghosh D, Benecke A, Katze MG. 2011. A chemokine gene expression signature derived from meta-analysis predicts the pathogenicity of viral respiratory infections. BMC Syst. Biol. 5:202. http://dx.doi.org/10.1186/1752-0509-5-202.
39. Tchitchek N, Eisfeld AJ, Tisoncik-Go J, Josset L, Gralinski LE, Becavin C, Tilton SC, Webb-Robertson BJ, Ferris MT, Totura AL, Li C, Neumann G, Metz TO, Smith RD, Waters KM, Baric R, Kawaoka Y, Katze MG. 2013. Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice. BMC Syst. Biol. 7:69. http://dx.doi .org/10.1186/1752-0509-7-69.
40. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y. 2013. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153:112-125. http://dx.doi.org/10.1016/j.cell.2013.02.027.
41. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, Thomas PG, Dennis EA, Aderem A. 2013. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154:213-227. http://dx.doi.org/10.1016/j.cell .2013.05.052.
42. Watanabe T, Tisoncik-Go J, Tchitchek N, Watanabe S, Benecke AG, Katze MG, Kawaoka Y. 2013. 1918 Influenza virus hemagglutinin (HA) and the viral RNA polymerase complex enhance viral pathogenicity, but only HA induces aberrant host responses in mice. J. Virol. 87:5239-5254. http://dx.doi.org/10.1128/JVI.02753-12.
43. Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, Ma C, Lycett SJ, Leung CY, Chen X, Li L, Hong W, Chai Y, Zhou L, Liang H, Ou Z, Liu Y, Farooqui A, Kelvin DJ, Poon LL, Smith DK, Pybus OG, Leung GM, Shu Y, Webster RG, Webby RJ, Peiris JS, Rambaut A, Zhu H, Guan Y. 2013. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature http://dx.doi.org/10.1038 /nature12515.
44. Wang C, Wang J, Su W, Gao S, Luo J, Zhang M, Xie L, Liu S, Liu X, Chen Y, Jia Y, Zhang H, Ding H, He H. 2014. Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J. Infect. Dis. 209:34-37. http://dx.doi.org/10.1093/infdis /jit478.
45. Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM. 2010. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J. Virol. 84:4194-4203. http://dx .doi.org/10.1128/JVI.02742-09.
46. Boon AC, Finkelstein D, Zheng M, Liao G, Allard J, Klumpp K, Webster R, Peltz G, Webby RJ. 2011. H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load. mBio 2:e00171-11. http://dx.doi.org/10.1128/mBio.00171-11.
47. Belser JA, Zeng H, Katz JM, Tumpey TM. 2011. Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. J. Infect. Dis. 203: 40-48. http://dx.doi.org/10.1093/infdis/jiq018.
48. Belser JA, Gustin KM, Maines TR, Blau DM, Zaki SR, Katz JM, Tumpey TM. 2011. Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic. J. Virol. 85:1563-1572. http://dx.doi.org/10.1128/JVI.02231-10.
49. Chan MCW, Chan RWY, Chan LLY, Mok CKP, Hui KPY, Fong JHM, Tao KP, Poon LLM, Nicholls JM, Guan Y, Peiris JM. 2013. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir. Med. 1:534 -542. http://dx.doi.org/10.1016 /S2213-2600(13)70138-3.
50. Friesenhagen J, Boergeling Y, Hrincius E, Ludwig S, Roth J, Viemann D. 2012. Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. J. Leukoc. Biol. 92:11-20. http://dx.doi.org/10.1189/jlb.0911479.
51. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do, Guan QY, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207. http://dx.doi.org/10.1038 /nm1477.
52. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. 2012. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76:16-32. http://dx.doi.org/10.1128/MMBR.05015-11.
53. Liao W, Goh FY, Betts RJ, Kemeny DM, Tam J, Bay BH, Wong WS. 2011. A novel anti-apoptotic role for apolipoprotein L2 in IFN-gammainduced cytotoxicity in human bronchial epithelial cells. J. Cell. Physiol. 226:397-406. http://dx.doi.org/10.1002/jcp.22345.
54. Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hui EK, Nayak DP, Fogelman AM. 2004. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 110:3252-3258. http://dx .doi.org/10.1161/01.CIR.0000147232.75456.B3.
55. Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy- containing docosatrienes. J. Immunol. 176:1848-1859. http://dx .doi.org/10.4049/jimmunol.176.3.1848.
56. Belisle SE, Tisoncik JR, Korth MJ, Carter VS, Proll SC, Swayne DE, Pantin-Jackwood M, Tumpey TM, Katze MG. 2010. Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection. J. Virol. 84:12576-12588. http://dx.doi.org/10.1128/JVI.01310-10.
57. Chen E, Wang F, Lv H, Zhang Y, Ding H, Liu S, Cai J, Xie L, Xu X, Chai C, Mao H, Sun J, Lin J, Yu Z, Li L, Chen Z, Xia S. 2013. The first avian influenza A (H7N9) viral infection in humans in Zhejiang Province, China: a death report. Front. Med. 7:333-344. http://dx.doi.org/10.1007 /s11684-013-0275-1.
58. Haidaris PJ. 1997. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 89:873-882.
59. Duan HO, Simpson-Haidaris PJ. 2006. Cell type-specific differential induction of the human gamma-fibrinogen promoter by interleukin-6. J. Biol. Chem. 281: 12451-12457. http://dx.doi.org/10.1074/jbc.M600294200.
60. Tan YJ, Tham PY, Chan DZ, Chou CF, Shen S, Fielding BC, Tan TH, Lim SG, Hong W. 2005. The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells. J. Virol. 79:10083-10087. http://dx.doi.org/10.1128/JVI.79.15.10083 -10087.2005.
61. Simpson-Haidaris PJ, Courtney MA, Wright TW, Goss R, Harmsen A, Gigliotti F. 1998. Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia. Infect. Immun. 66:4431- 4439.
62. Chapman HA, Jr, Allen CL, Stone OL, Fair DS. 1985. Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J. Clin. Invest. 75:2030-2037.
63. Van Leer C, Stutz M, Haeberli A, Geiser T. 2005. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro. Thromb. Haemost. 94:1257-1264.
64. Perrio MJ, Ewen D, Trevethick MA, Salmon GP, Shute JK. 2007. Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins. Clin. Exp. Allergy 37:1688-1700. http://dx.doi.org/10.1111/j.1365-2222.2007 .02829.x.
65. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H. 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146:980-991. http://dx.doi.org/10.1016/j.cell.2011 .08.015.
66. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B. 2013. PAR1 contributes to influenza A virus pathogenicity in mice. J. Clin. Invest. 123:206-214. http://dx.doi.org/10.1172/JCI61667.
67. Berri F, Rimmelzwaan GF, Hanss M, Albina E, Foucault-Grunenwald ML, Le VB, Vogelzang-van Trierum SE, Gil P, Camerer E, Martinez D, Lina B, Lijnen R, Carmeliet P, Riteau B. 2013. Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog. 9:e1003229. http://dx.doi.org/10.1371/journal.ppat.1003229.
68. Yang H, Ko HJ, Yang JY, Kim JJ, Seo SU, Park SG, Choi SS, Seong JK, Kweon MN. 2013. Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection. J. Infect. Dis. 207:50-60. http://dx.doi.org/10.1093 /infdis/jis651.
69. Dacho C, Dacho A, Geissler A, Hauser C, Nowak K, Beck G. 2013. Catecholamines reduce dose-dependent oedema formation and inflammatory reaction in an isolated rat lung model. In Vivo 27:49-56.
70. de Chazal I, Parham WM, III, Liopyris P, Wijdicks EF. 2005. Delayed cardiogenic shock and acute lung injury after aneurysmal subarachnoid hemorrhage. Anesth. Analg. 100:1147-1149. http://dx.doi.org/10.1213/01 .ANE.0000147704.90285.2A.
71. Kishi K, Jin D, Takai S, Muramatsu M, Katayama H, Tamai H, Miyazaki M. 2006. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats. Pediatr. Res. 60: 77-82. http://dx.doi.org/10.1203/01.pdr.0000219431.45075.d9.
72. Kalemci S, Dirican N, Cetin ES, Sozen H, Uner AG, Yaylali A, Aksun S, Karacam V, Ulger E, Sutcu R, Dirican A. 2013. The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice. Eur. Rev. Med. Pharmacol. Sci. 17:3334-3340.